FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Gang Chen

Research Profile

Chemicals & Drugs

Concepts & Ideas

Disorders

Physiology

Postmenopause

Co-author Network

Publications

TOP 3
Yong-Cheng Wang; Gang Chen; George Y H Chi
A ratio test in active control non-inferiority trials with a time-to-event endpoint.
Lilia Talarico; Gang Chen; Richard Pazdur
Enrollment of elderly patients in clinical trials for cancer drug registration: a 7-year experience by the US Food and Drug Administration.
Gang Chen; Yong-Cheng Wang; George Y H Chi
Hypotheses and type I error in active-control noninferiority trials.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Gang Chen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2006: Yong-Cheng Wang; Gang Chen; George Y H Chi
A ratio test in active control non-inferiority trials with a time-to-event endpoint.
Journal of biopharmaceutical statistics 2006;16(2):151-64.
2004: Lilia Talarico; Gang Chen; Richard Pazdur
Enrollment of elderly patients in clinical trials for cancer drug registration: a 7-year experience by the US Food and Drug Administration.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(22):4626-31.
2004: Gang Chen; Yong-Cheng Wang; George Y H Chi
Hypotheses and type I error in active-control noninferiority trials.
Journal of biopharmaceutical statistics 2004;14(2):301-13.
2004: Martin H Cohen; Grant A Williams; R Sridhara; Gang Chen; W David McGuinn; David Morse; Sophia Abraham; Atiqur Rahman; Chenyi Liang; Richard T Lostritto; Amy Baird; Richard Pazdur
United States Food and Drug Administration Drug Approval summary: Gefitinib (ZD1839; Iressa) tablets.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(4):1212-8.
2004: R Sridhara; Gang Chen; George Y H Chi; Donna J Griebel
Evaluation of health-related quality-of-life measures in oncology drug product applications: issues and concerns.
Journal of biopharmaceutical statistics 2004;14(1):23-30.
2003: Peter F Bross; Amy Baird; Gang Chen; Josephine M Jee; Richard T Lostritto; David E Morse; Liliam A Rosario; Gene M Williams; Peiling Yang; Atiqur Rahman; Grant Williams; Richard Pazdur
Fulvestrant in postmenopausal women with advanced breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(12):4309-17.
2003: Amna Ibrahim; Nancy Scher; Grant Williams; R Sridhara; Ning Li; Gang Chen; John Leighton; Brian Booth; Jogarao V S Gobburu; Atiqur Rahman; Yung Hsieh; Rebecca Wood; Debra Vause; Richard Pazdur
Approval summary for zoledronic acid for treatment of multiple myeloma and cancer bone metastases.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(7):2394-9.
2003: John R Johnson; Peter Bross; Martin Cohen; Mark Rothmann; Gang Chen; Anne Zajicek; Jogarao V S Gobburu; Atiqur Rahman; Ann Staten; Richard Pazdur
Approval summary: imatinib mesylate capsules for treatment of adult patients with newly diagnosed philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(6):1972-9.
2003: Mark Rothmann; Ning Li; Gang Chen; George Y H Chi; Robert Temple; Hsiao-Hui Tsou
Design and analysis of non-inferiority mortality trials in oncology.
Statistics in medicine 2003;22(2):239-64.
2003: Martin H Cohen; Grant A Williams; R Sridhara; Gang Chen; Richard Pazdur
FDA drug approval summary: gefitinib (ZD1839) (Iressa) tablets.
The oncologist 2003;8(4):303-6.
2002: Ramzi Dagher; Martin Cohen; Gene Williams; Mark Rothmann; Jogarao V S Gobburu; Gabriel Robbie; Atiqur Rahman; Gang Chen; Ann Staten; Donna Griebel; Richard Pazdur
Approval summary: imatinib mesylate in the treatment of metastatic and/or unresectable malignant gastrointestinal stromal tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(10):3034-8.
2002: Martin H Cohen; Grant Williams; John R Johnson; John Duan; Jogarao V S Gobburu; Atiqur Rahman; Kimberly Benson; John Leighton; Sung K Kim; Rebecca Wood; Mark Rothmann; Gang Chen; Khin Maung U; Ann Staten; Richard Pazdur
Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(5):935-42.
2002: Martin H Cohen; John R Johnson; Ning Li; Gang Chen; Richard Pazdur
Approval summary: letrozole in the treatment of postmenopausal women with advanced breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(3):665-9.
2001: Peter F Bross; J Beitz; Gang Chen; X H Chen; E Duffy; L Kieffer; S Roy; R Sridhara; Atiqur Rahman; Grant Williams; Richard Pazdur
Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(6):1490-6.